Moolec Science SA (MLEC)
1.170
-0.03
(-2.11%)
USD |
NASDAQ |
May 31, 16:00
1.18
+0.01
(+0.85%)
After-Hours: 20:00
Moolec Science Enterprise Value: 49.97M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 49.97M |
| May 30, 2024 | 50.91M |
| May 29, 2024 | 49.96M |
| May 28, 2024 | 50.34M |
| May 24, 2024 | 51.09M |
| May 23, 2024 | 51.46M |
| May 22, 2024 | 51.84M |
| May 21, 2024 | 53.34M |
| May 20, 2024 | 55.60M |
| May 17, 2024 | 51.09M |
| May 16, 2024 | 51.09M |
| May 15, 2024 | 52.59M |
| May 14, 2024 | 53.34M |
| May 13, 2024 | 53.34M |
| May 10, 2024 | 54.85M |
| May 09, 2024 | 55.60M |
| May 08, 2024 | 56.72M |
| May 07, 2024 | 58.60M |
| May 06, 2024 | 58.23M |
| May 03, 2024 | 58.98M |
| May 02, 2024 | 56.72M |
| May 01, 2024 | 56.35M |
| April 30, 2024 | 59.35M |
| April 29, 2024 | 57.47M |
| April 26, 2024 | 60.48M |
| Date | Value |
|---|---|
| April 25, 2024 | 59.35M |
| April 24, 2024 | 60.86M |
| April 23, 2024 | 71.00M |
| April 22, 2024 | 98.79M |
| April 19, 2024 | 58.60M |
| April 18, 2024 | 57.85M |
| April 17, 2024 | 58.98M |
| April 16, 2024 | 54.85M |
| April 15, 2024 | 49.21M |
| April 12, 2024 | 51.09M |
| April 11, 2024 | 50.71M |
| April 10, 2024 | 51.41M |
| April 09, 2024 | 51.84M |
| April 08, 2024 | 52.97M |
| April 05, 2024 | 51.46M |
| April 04, 2024 | 55.22M |
| April 03, 2024 | 55.82M |
| April 02, 2024 | 57.85M |
| April 01, 2024 | 56.35M |
| March 28, 2024 | 57.85M |
| March 27, 2024 | 57.85M |
| March 26, 2024 | 58.98M |
| March 25, 2024 | 58.98M |
| March 22, 2024 | 58.60M |
| March 21, 2024 | 54.09M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
49.21M
Minimum
Apr 15 2024
712.76M
Maximum
Jan 06 2023
116.28M
Average
106.62M
Median
May 08 2023
Enterprise Value Benchmarks
| Alvotech | 4.794B |
| Procaps Group SA | 574.55M |
| Sunshine Biopharma Inc | -5.731M |
| Bio-Path Holdings Inc | 3.29M |
| Palisade Bio Inc | -6.817M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.784M |
| Revenue (Quarterly) | 0.2521M |
| Total Expenses (Quarterly) | 2.045M |
| EPS Diluted (Quarterly) | -0.05 |
| Gross Profit Margin (Quarterly) | 92.05% |
| Profit Margin (Quarterly) | -707.4% |
| Earnings Yield | -11.11% |